Internal projects

Code	Title	Period	Principal Investigator at the Institute of Oncology
OI-3-26	Reliability of Digital Cervical Cytology for the Detection of High-Grade Squamous Intraepithelial Lesions and Cervical Cancer	22. 6. 2026 - 21. 5. 2029	Asst. Špela Cerar, M.Sc.
OI-4-25	Assessment of Resting Energy Expenditure Based on Intestinal Functional Status	1. 9. 2025 - 31. 8. 2028	Asist. Klemen Schara, M.Sc. Nutr., Head of the Clinical Dietetics Subsection
OI-2-25	pRevenT: Randomized controlled study of (early) prophylactic irradiation to prevent bone complications in patients with metastatic solid tumors	1. 9. 2025 - 31. 8. 2028	Assoc. Prof. Jasna But Hadžić, MD, PhD
OI-1-25	Additional definition of the clinical significance of structural variants and variants affecting RNA structure in genes associated with hereditary cancers: Introduction of the method	1. 8. 2025 - 31. 7. 2028	Asst. Vita Šetrajčič Dragoš, PhD, Master of Medical Science, Sweden
OI-3-25	Gene therapy with IL12 in combination with electrochemotherapy for the treatment of melanoma; a preclinical study	1. 7. 2025 - 30. 6. 2028	Sen. Res. Assoc. Maša Omerzel, PhD, MPharm
OI-3-24	Molecular markers of response to radiotherapy in non-invasive breast cancer	4. 11. 2024 - 3. 11. 2027	Asst. Prof. Tanja Marinko, MD, PhD
OI-13-24	Antitumor effect of electrochemotherapy on osteosarcoma in vitro and in vivo	1. 9. 2024 - 31. 8. 2027	Asst. Prof. Urša Lampreht Tratar, PhD, DVM
OI-12-24	Pilot project on individualized management of genitourinary syndrome in menopause in women after oncological treatment	1. 9. 2024 - 31. 8. 2027	Asst. Prof. Nina Kovačević, MD, PhD, Specialist in Gynecology and Obstetrics
OI-10-24	Genetically modified mesenchymal stem cells for cancer immunotherapy	1. 9. 2024 - 31. 8. 2027	Sr. Res. Assoc. Asst. Prof. Urska Kamensek, Ph.D. (Biol.)
OI-7-24	The Role of the Endocannabinoid System in the Treatment of Triple-Negative Breast Cancer with Immunotherapy	1. 9. 2024 - 31. 8. 2027	Senior research associate Simona Kranjc Brezar, PhD
OI-5-24	Diagnostic significance of silencing genes associated with breast cancer in lesions of uncertain malignant potential	1. 9. 2024 - 31. 8. 2027	Assist. Romi Cencelj-Arnež, MD
OI-1-24	Determination of copper and other trace elements in serum samples of patients with biliary tract cancers	1. 9. 2024 - 31. 8. 2027	Asst. Prof. Martina Reberšek, MD, PhD, Medical Oncologist
OI-2-24	Pilot study on individualized comprehensive rehabilitation of patients with colon and rectal cancer: Phase 2 and 3 of the project	1. 8. 2024 - 31. 7. 2027	Prof. Nada Rotovnik Kozjek, MD, PhD
OI-11-24	Determination of RAD51/geminin/γH2AX immunohistochemical expression in triple-negative breast cancers with confirmed BRCA1 or BRCA2 mutation and in breast cancers of other molecular types	1. 6. 2024 - 31. 5. 2027	Asst. Grega Kragelj, MD
OI-9-24	The use of miRNAs to predict treatment response and acute toxicity after radiotherapy in prostate cancer patients: clinical application of miRNAs for the development of personalized treatment	1. 6. 2024 - 31. 5. 2027	Asst. Prof. Blaž Grošelj, MD, PhD
OI-6-24	The role of cytopathology in defining the molecular characteristics of epithelial ovarian cancer important for treatment and in studying the immune response to the disease	1. 6. 2024 - 31. 5. 2027	Asst. Prof. Erik Škof, MD, PhD
OI-4-23	Frequency of somatic mosaicism in the APC gene in patients with adenomatous	1. 9. 2023 - 31. 8. 2026	Research Associate Vida Stegel, PhD
OI-2-23	Studying the role of circulating tumor cell clusters in patients with high-risk early breast cancer – GALIA	1. 9. 2023 - 31. 8. 2026	Assoc. Prof. Cvetka Grašič Kuhar, MD, PhD
OI-2-23	Effectiveness of immunotherapy as first-line treatment of metastatic melanoma in Slovenia and identification of prognostic and predictive biomarkers from the primary tumor, stool, and body fluids	1. 9. 2023 - 31. 8. 2026	Assoc. Prof. Tanja Mesti, MD, PhD
OI-1-23	Development and use of a web application for monitoring complications of radiation therapy in cancer patients and analysis of its effectiveness	1. 9. 2023 - 31. 8. 2026	Asst. Prof. Helena Barbara Zobec Logar, MD, PhD
OI-8-23	The significance of plasma and urinary vesicular miRNAs and PD-L1 in predicting the response to immunotherapy in advanced renal cell carcinoma	1. 9. 2023 - 31. 8. 2026	Assoc. Prof. Boštjan Šeruga, MD, PhD
OI-7-23	The use of electrochemotherapy in women with vulvar cancer	1. 9. 2023 - 31. 8. 2026	Asst. Prof. Sebastjan Merlo, MD, PhD, Specialist in Gynecology and Obstetrics
OI-6-23	Reliability of reporting family history of cancer by patients and their relatives - a prospective study	1. 9. 2023 - 31. 8. 2026	Asst. Prof. Mateja Krajc, MD, PhD.

Name	Purpose	Lifetime
_pk_id	Counting web site visitors.	13 months
_pk_ref	Tracking from which sites users come to our web pages.	6 months
_pk_ses	Counting web site visits.	30 minutes
_ga	Used to distinguish users.	2 years
_ga_--container-id--	Persists session state.	2 years

Projects

Internal projects

Internal projects

Completed internal projects

National projects

International projects